Unrivaled Coverage

From market-moving scoops and exclusive interviews to investigative reports and insightful commentary — this is Reuters Best.

REUTERS EXCLUSIVELY REPORTED U.S. APPROVAL OF MERCK CANCER IMMUNOTHERAPY EXPECTED SOON

Reuters exclusively reported that U.S. regulators are likely to approve Merck & Co’s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline. If approved by the Food...

Read More

REUTERS IFR AHEAD IN REPORTING SINOPEC PLANNING $1.5 BLN HONG KONG IPO FOR OILFIELD SERVICES UNIT

Reuters IFR was ahead in reporting that Asia’s largest refiner Sinopec is planning a $1.5 billion Hong Kong initial public offering for its oilfield services unit in the first half of 2015. Investment banks were recently invited to pitch for...

Read More

JOURNALIST SPOTLIGHT: DMITRY MADORSKY ON CAPTURING EXCLUSIVE LIVE FOOTAGE OF RUSSIA AID CONVOY MOVING INTO UKRAINE

Last week, Reuters scored an exclusive live shot of a Russian aid convoy heading to Ukraine. For journalists trying to follow the...

Read More

1 of 1

ARCHIVE

Search on topics and regions relevant to your business.

Go to archive